Prospective Study on Prognosis of Cardiac Resynchronized Therapy (CRT), Implantable Cardioverter Defibrillator (ICD) Implantation in Patients With Congestive Heart Failure (CHF)
1 other identifier
observational
1,000
1 country
1
Brief Summary
CRT and ICD has known as decreasing cardiac mortality in patient with heart failure. Especially, it has reported that CRT improved cardiac systolic function, quality of life of patients with heart failure. However, CRT and primary ICD was not generalized in Korea. So the investigators will register patients who implant CRT or ICD (primary), and follow them up. During scheduled follow up, all patients will perform echocardiography, 6 minute walking test, EKG, Holter monitoring and questionnaire on QOL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 13, 2014
CompletedFirst Posted
Study publicly available on registry
May 15, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedDecember 3, 2019
November 1, 2019
10 years
May 13, 2014
November 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Transthoracic echocardiography (TTE)
before enrollment
Transthoracic echocardiography (TTE)
12 month later afer enrollment
EKG
for Ventricular arrhythmia events
before enrollment
EKG
for Ventricular arrhythmia events
1 month later after enrollment
EKG
for Ventricular arrhythmia events
6 month later after enrollment
EKG
for Ventricular arrhythmia events
12 month later after enrollment
NYHA(New York Heart Association) evaluation
For functional capacity \- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.
before enrollment
NYHA(New York Heart Association) evaluation
For functional capacity \- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.
1 month later after enrollment
NYHA(New York Heart Association) evaluation
For functional capacity \- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.
6 month later after enrollment
NYHA(New York Heart Association) evaluation
For functional capacity \- The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina.
12 month later after enrollment
6 minute walking test
for functional capacity
before enrollment
6 minute walking test
for functional capacity
12 month later afer enrollment
Secondary Outcomes (4)
Questionnaire on Quality of Life(QOL) : EQ-5D-3L (Optional)
before enrollment
Questionnaire on Quality of Life(QOL) : EQ-5D-3L (Optional)
12 month later afer enrollment
Cardiac MRI or Cardiac CT
before enrollment
Cardiac MRI or Cardiac CT
12 month later afer enrollment
Study Arms (1)
ICD/CRT registry
ICD / CRTregistry in Severance or Ewha Womans University Medical Center
Interventions
cardiac resynchronized therapy (CRT), implantable cardioverter defibrillator (ICD) implantation
Eligibility Criteria
patients with congestive heart failure(including heart failure with preserved EF or reduced EF) who are undergone cardiac resynchronized therapy (CRT), implantable cardioverter defibrillator (ICD) implantation
You may qualify if:
- Age \>=18
- LV ejection fraction \<40% or Clinical HF Symptom with (LV ejection fraction \>40%)
- medication for at least 3month
You may not qualify if:
- \. patient who refuse to enroll the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance hospital
Seoul, 120-752, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2014
First Posted
May 15, 2014
Study Start
April 1, 2014
Primary Completion
April 1, 2024
Study Completion
April 1, 2024
Last Updated
December 3, 2019
Record last verified: 2019-11